Suppr超能文献

下咽鳞状细胞癌术后辅助化疗决策的预后列线图

Prognostic Nomogram for Postoperative Hypopharyngeal Squamous Cell Carcinoma to Assist Decision Making for Adjuvant Chemotherapy.

作者信息

Zhang Di, Li Lixi, Wen Tingyu, Wu Yun, Ma Fei

机构信息

Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Panjiayuan Nan Road 17, Beijing 100021, China.

出版信息

J Clin Med. 2022 Sep 30;11(19):5801. doi: 10.3390/jcm11195801.

Abstract

We aimed to investigate the effect of lymph node parameters on postoperative hypopharyngeal squamous cell carcinoma (HSCC) and to establish a nomogram to predict its prognosis and assist in adjuvant chemotherapy decisions. A retrospective analysis of postoperative HSCC in the Surveillance, Epidemiology, and End Results database (2004-2019) was performed. Cutoff points for continuous variables were determined by X-tile software. Univariate and multivariate analyses were performed to identify prognostic factors on overall survival (OS), and these variables were used to construct a nomogram. The nomogram's accuracy was internally validated using concordance index, area under the curve, calibration plot, and decision curve analyses. Furthermore, the value of chemotherapy in each risk subgroup was assessed separately based on individualized scores from the nomogram. In total, 404 patients were eligible for analysis, and the median OS was 39 months. Age, origin, primary site, T stage, number of lymph nodes examined, lymph node ratio, and radiotherapy were identified as prognostic factors for OS and incorporated into the nomogram. In both the training and validation cohorts, favorable performance was exhibited compared with the other stage systems, and patients could be classified into low-, intermediate-, and high-risk subgroups. Chemotherapy significantly improved the OS in the high-risk subgroup, whereas chemotherapy did not confer a survival benefit in the low- or intermediate-risk groups. The lymph node parameter-based nomogram model can better stratify the prognosis of HSCC patients and screen out patients who would benefit from chemotherapy, suggesting that the model could be used as a reference for clinical decision making and to avoid overtreatment.

摘要

我们旨在研究淋巴结参数对下咽鳞状细胞癌(HSCC)术后的影响,并建立列线图以预测其预后并辅助辅助化疗决策。对监测、流行病学和最终结果数据库(2004 - 2019年)中的HSCC术后患者进行回顾性分析。连续变量的截断点由X-tile软件确定。进行单因素和多因素分析以确定总生存期(OS)的预后因素,并将这些变量用于构建列线图。使用一致性指数、曲线下面积、校准图和决策曲线分析对列线图的准确性进行内部验证。此外,根据列线图的个体化评分分别评估每个风险亚组中化疗的价值。共有404例患者符合分析条件,中位OS为39个月。年龄、起源、原发部位、T分期、检查的淋巴结数量、淋巴结比率和放疗被确定为OS的预后因素并纳入列线图。在训练队列和验证队列中,与其他分期系统相比均表现出良好的性能,并且患者可分为低、中、高风险亚组。化疗显著改善了高风险亚组的OS,而化疗在低风险或中风险组中未带来生存获益。基于淋巴结参数的列线图模型可以更好地对HSCC患者的预后进行分层,并筛选出能从化疗中获益的患者,这表明该模型可作为临床决策的参考并避免过度治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f7b/9573651/daa73113fa66/jcm-11-05801-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验